GlassScriptPhysician profile
Amy B Boots
NPI 1053632927
$2,223.23
in general payments reported to CMS, 2019-2025
24 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $146 · 2021: $245 · 2022: $53.87 · 2023: $180 · 2024: $54.98 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $235.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,144.75 | 2019-2025 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $209.78 | 2019-2021 | |
| Abbvie INC. | $198.14 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $91.55 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.82 | 2019-2020 | |
| Daiichi Sankyo INC. | $74.34 | 2019-2021 | |
| Organon LLC | $60.93 | 2021-2022 | |
| Coloplast Corp | $54.38 | 2023 | Altis |
| Minerva Surgical, INC | $44.25 | 2020 | |
| Amag Pharmaceuticals, INC. | $38.06 | 2019 | |
| Duchesnay USA Incorporated | $24.37 | 2019 | |
| Coopersurgical, INC. | $23.99 | 2024 | Paragard T 380a |
| Gynesonics, INC. | $20.89 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Allergan, INC. | $19.92 | 2019 | |
| Therapeuticsmd, INC. | $19.67 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $16.98 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mylan Pharmaceuticals INC. | $15.53 | 2021 | |
| Boston Scientific Corporation | $14.28 | 2022 | |
| Evofem Biosciences, INC. | $14.16 | 2021 | |
| Pfizer INC. | $14.01 | 2024 | |
| Avion Pharmaceuticals | $13.64 | 2020 | |
| Lupin INC. | $13.26 | 2019 | |
| Aspira Women'S Health INC | $10.53 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Boots listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.